Minaris Medical America
bd_a8221c7f27351854 · schema v1 · pii pii-v1
Full breach record for Minaris Medical America →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group Akira on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Source: Ransomware.live
Post text · scraped from the leak site
Minaris Medical America, formally known as MAST Immunosystems Inc (1979-1996) and Hitachi Chemical Diagnostics (1996-2021) was the first company to introduce a multiplex in vitro diagnostic test for allergies and one of the first to introduce a chemiluminescen t assay system for the detection of lgE antibodies. We are ready to upload a lot of sensitive corporate documents suc h as: contact numbers and e-mail addresses of employees and custo mers, financial data (audits, payment details, reports), confiden tial licenses, agreements and contracts, etc.
Source provenance
- Source URL
- https://www.ransomware.live/
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
- Filed at
- Feb 20, 2025
- Raw hash
- 1518d15d2342dc0d23bf819f32058de75cf6353148c117d13f49884533d7ee43
Reporting entity
- Name
- akira
Victim entity
- Name
- Minaris Medical Americanorm: minaris medical america
- Domain
- minarismedical.com
- Industry
- Healthcare
What this source establishes
- Source ceiling
- A leak-site claim can't tell us: discovery date · materiality · notification · affected count · confirmed data types · compliance clock. These stay blank until a regulatory filing or victim disclosure lands.
- Attack vector
- Ransomware· akira
- Threat actor
- AkiraExternalFinancial
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.